Rapid Detection of Airway Pathogens for Lung Transplantation
Public ClinicalTrials.gov record NCT03933878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pneumonias and lower respiratory tract infections can have important long-term consequences, particularly in the context of lung transplantation, where pneumonia is a major cause of death. Candidate organs and lung transplant recipients undergo bronchoscopic inspection to assess for lower respiratory tract infection, but traditional culture methods take time, leading to increased risk from inappropriate therapy. The investigators hypothesize that the rapid detection of lower respiratory tract infection, using a semi-quantitative multiplex molecular assay, can decrease the time to appropriate clinical decision making.
Study identification
- NCT ID
- NCT03933878
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 200 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 18, 2019
- Primary completion
- Mar 4, 2021
- Completion
- Mar 4, 2021
- Last update posted
- Mar 17, 2021
2019 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF Parnassus | San Francisco | California | 94143 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Lung Transplantation trials
Other public records listing Lung Transplantation. Sorted by last update posted; newest first. Not a recommendation.
- NCT07747337: Respiratory, Limb Muscle Properties, and Physical Performance in Adult Lung Transplant Recipients Recruiting
- NCT00552357: Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation Recruiting
- NCT00457847: Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation Active, not recruiting
- NCT05837663: Trifecta-Lung cfDNA-MMDx Study Recruiting
- NCT06948097: Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies Not yet recruiting
- NCT06018766: LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03933878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2021 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03933878 live on ClinicalTrials.gov.